A cost-effectiveness analysis comparing two different strategies in advanced maternal age: Combined first-trimester screening and maternal blood cell-free DNA testing

A cost-effectiveness analysis comparing two different strategies in advanced maternal age: Combined first-trimester screening and maternal blood cell-free DNA testing

Objective: To estimate cost efficacy of first-trimester screening strategies based on nuchal translucency (NT) and maternal blood cell-free DNA (cfDNA) testing in women with advanced maternal age (AMA). Materials and methods: This was a retrospective population-based analysis of all pregnant women w...

Full description

Bibliographic Details
Main Authors:	Min Pan, Lv-Yin Huang, Li Zhen, Dong-Zhi Li
Format:	Article
Language:	English
Published:	Elsevier 2018-08-01
Series:	Taiwanese Journal of Obstetrics & Gynecology
Online Access:	http://www.sciencedirect.com/science/article/pii/S1028455918301293

Similar Items

Maternal Reassurance, Satisfaction, and Anxiety after First-Trimester Screening for Aneuploidies: Comparison between Contingent Screening and Universal Cell-Free DNA Testing
by: Anna Luna Tramontano, et al.
Published: (2024-06-01)

Implementation of Maternal Blood Cell Free DNA Testing in Early Screening for Aneuploidies
by: María del Mar Gil, et al.
Published: (2019-07-01)

Effect of maternal reproductive factors on prenatal screening rates in the first trimester
by: P. M. Samchuk, et al.
Published: (2020-11-01)

Reviewing Accuracy of First Trimester Screening for Preeclampsia Using Maternal Factors and Biomarkers
by: Malone SL, et al.
Published: (2022-09-01)

Association of maternal blood mercury concentration during the first trimester of pregnancy with birth outcomes
by: Wei Li, et al.
Published: (2024-09-01)

Maternal levels of endocrine disrupting chemicals in the first trimester of pregnancy are associated with infant cord blood DNA methylation
by: Luke Montrose, et al.
Published: (2018-03-01)

Effect of maternal polycystic ovary syndrome (PCOS) on screening of aneuploidy in the first and second trimesters
by: Narjes Hassan Haivadi, et al.
Published: (2023-08-01)

Maternal Zika Virus Infection in the First Trimester and Fetal Stigmata in the Third Trimester
by: Divya Singh, et al.
Published: (2023-07-01)

Maternal glycemia of first trimester of pregnancy and gestational diabetes
by: María Cristina Faingold
Published: (2021-11-01)

Influence of Maternal Toxoplasmosis on the Second-Trimester Aneuploidy Screening Test
by: Umit Gorkem, et al.
Published: (2018-08-01)

A bioplex analysis of cytokines and chemokines in first trimester maternal plasma to screen for predictors of miscarriage.
by: Natalie J Hannan, et al.
Published: (2014-01-01)

Detection of Embryonic Trisomy 21 in the First Trimester Using Maternal Plasma Cell-Free RNA
by: Carl P. Weiner, et al.
Published: (2022-06-01)

Maternal cardiovascular and endothelial function from first trimester to postpartum.
by: Vassiliki Kolovetsiou-Kreiner, et al.
Published: (2018-01-01)

Maternal and perinatal outcome in women with threatened miscarriage in the first trimester
by: G D Maiti, et al.
Published: (2013-01-01)

Performance of cell free DNA as a screening tool based on the results of first trimester screening
by: Mahtab Motevasselian, et al.
Published: (2024-12-01)

Associations between first-trimester screening biomarkers and maternal characteristics with gestational diabetes mellitus in Chinese women
by: Yu-Ting Lu, et al.
Published: (2024-08-01)

The effect of a vanishing twin on first- and second-trimester maternal serum markers and ultrasound screening for aneuploidy
by: Da Rae Lee, et al.
Published: (2023-11-01)

Extreme βHCG levels in first trimester screening are risk factors for adverse maternal and fetal outcomes
by: Sarang Younesi, et al.
Published: (2023-01-01)

The effect of maternal alcohol and drug abuse on first trimester screening analytes: a retrospective cohort study
by: Anni Lehikoinen, et al.
Published: (2020-09-01)

Genetic deconvolution of fetal and maternal cell-free DNA in maternal plasma enables next-generation non-invasive prenatal screening
by: Chenming Xu, et al.
Published: (2022-10-01)

Exposure to heavy metals and trace minerals in first trimester and maternal blood pressure change over gestation
by: Tiange Liu, et al.
Published: (2021-08-01)

Revisiting the Role of First Trimester Homocysteine as an Index of Maternal and Fetal Outcome
by: Mariano Mascarenhas, et al.
Published: (2014-01-01)

Effects of maternal characteristics and medical history on first trimester biomarkers for preeclampsia
by: Johnatan Torres-Torres, et al.
Published: (2023-01-01)

Maternal and perinatal outcomes in pregnant women with first trimester vaginal bleeding.
by: Zhila Amirkhani, et al.
Published: (2013-06-01)

Cytokine Patterns in Maternal Serum From First Trimester to Term and Beyond
by: Anders Hagen Jarmund, et al.
Published: (2021-10-01)

Prediction of Preeclampsia by Maternal Factors and Biophysical Markers During the First-trimester
by: Urjindelger Tserensambuu, et al.
Published: (2017-11-01)

First Trimester Maternal Body Mass Index and Ges-tational Weight Gain and Their Association with Feto-Maternal Outcomes
by: Sanjay Patil, et al.
Published: (2023-12-01)

Effect of subchorionic hematoma on first-trimester maternal serum free β-hCG and PAPP-A levels
by: Arife Akay, et al.
Published: (2024-08-01)

Improved first trimester maternal iodine status with preconception supplementation: The Women First Trial
by: Amy E. Young, et al.
Published: (2021-10-01)

Diagnostic value of maternal alpha-fetoprotein variants in second-trimester biochemical screening for trisomy 21 and 18
by: Yiming Chen, et al.
Published: (2022-08-01)

Exosomal small RNA profiling in first-trimester maternal blood explores early molecular pathways of preterm preeclampsia
by: Luca Gál, et al.
Published: (2024-02-01)

First Trimester Pregnancy Loss and the Expression of alternatively spliced NKp30 isoforms in Maternal Blood and Placental Tissue
by: Avishai eShemesh, et al.
Published: (2015-06-01)

A maternal sweet diet is associated with the gut dysbiosis in the first trimester of pregnancy
by: Navid Momeni, et al.
Published: (2024-12-01)

Inflammatory Cytokines in Maternal Circulation and Placenta of Chromosomally Abnormal First Trimester Miscarriages
by: Jean Calleja-Agius, et al.
Published: (2012-01-01)

First-Trimester Maternal Vitamin D Levels and Risk for Gestational Diabetes Mellitus
by: Kağan Güngör, et al.
Published: (2021-09-01)

The Values of First-trimester Maternal Serum Markers in Predicting Poor Obstetric Outcomes
by: Şafak Yılmaz Baran, et al.
Published: (2019-07-01)

The relationship between maternal hemoglobin concentration in the first trimester of pregnancy and gestational diabetes
by: Narjes Noori, et al.
Published: (2022-09-01)

Cell-free DNA screening for sex chromosome aneuploidies by non-invasive prenatal testing in maternal plasma
by: Yipeng Wang, et al.
Published: (2020-03-01)

Prenatal diagnosis of distal 5p deletion syndrome associated with an abnormal first-trimester maternal serum screening result
by: Chih-Ping Chen
Published: (2024-03-01)

First trimester screening for trisomy 21 in gestational week 8-10 by ADAM12-S as a maternal serum marker
by: Guitton Marie, et al.
Published: (2010-10-01)